NVASC, INC. Trademark

Trademark Overview

On Friday, January 1, 2021, a trademark application was filed for NVASC, INC. with the United States Patent and Trademark Office. The USPTO has given the NVASC, INC. trademark a serial number of 90444055. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 18, 2024. This trademark is owned by NVasc, Inc.. The NVASC, INC. trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Conducting early evaluations in the field of new pharmaceuticals; Pharmaceutical drug development services

General Information

Serial Number90444055
Word MarkNVASC, INC.
Filing DateFriday, January 1, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 18, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 17, 2021

Trademark Statements

NOT AVAILABLE"INC."
Goods and ServicesConducting early evaluations in the field of new pharmaceuticals; Pharmaceutical drug development services

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, March 31, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNVasc, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAtherton, CA 940272013
Party NameNVasc, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAtherton, CA 940272013

Trademark Events

Event DateEvent Description
Tuesday, January 5, 2021NEW APPLICATION ENTERED
Wednesday, March 31, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, July 12, 2021ASSIGNED TO EXAMINER
Monday, July 12, 2021EXAMINERS AMENDMENT -WRITTEN
Monday, July 12, 2021EXAMINERS AMENDMENT E-MAILED
Monday, July 12, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, July 12, 2021EXAMINER'S AMENDMENT ENTERED
Monday, July 12, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 28, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 17, 2021PUBLISHED FOR OPPOSITION
Tuesday, August 17, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 12, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, December 8, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, December 8, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, December 8, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, February 7, 2022SOU TEAS EXTENSION RECEIVED
Monday, February 7, 2022SOU EXTENSION 1 FILED
Monday, February 7, 2022SOU EXTENSION 1 GRANTED
Wednesday, February 9, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 14, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, September 14, 2022SOU EXTENSION 2 FILED
Wednesday, September 14, 2022SOU EXTENSION 2 GRANTED
Friday, September 16, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 10, 2023SOU TEAS EXTENSION RECEIVED
Monday, April 10, 2023SOU EXTENSION 3 FILED
Monday, April 10, 2023SOU EXTENSION 3 GRANTED
Wednesday, April 12, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 22, 2023SOU TEAS EXTENSION RECEIVED
Friday, September 22, 2023SOU EXTENSION 4 FILED
Friday, September 22, 2023SOU EXTENSION 4 GRANTED
Tuesday, September 26, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 29, 2024SOU EXTENSION 5 FILED
Friday, March 29, 2024SOU TEAS EXTENSION RECEIVED
Friday, March 29, 2024SOU EXTENSION 5 GRANTED
Saturday, March 30, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 18, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, November 18, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

nvasc drug development services pharmaceutical pharmaceuticals early evaluations field conducting